#1 Clinical Trials Search in Europe

Calcitriol

Calcitriol, the active form of vitamin D, is being studied in clinical trials for its potential therapeutic effects on various medical conditions. These trials aim to evaluate the safety and efficacy of calcitriol in treating diseases such as breast cancer, lung cancer, COVID-19, chronic kidney disease, immune thrombocytopenia, and more. Researchers are exploring different administration methods, dosages, and combinations with other treatments to determine the optimal use of calcitriol in improving patient outcomes.

Table of Contents

What is Calcitriol?

Calcitriol is a medication that is the active form of vitamin D, also known as 1,25-dihydroxyvitamin D. It is often referred to by its brand names, which include Rocaltrol[1]. Calcitriol is a naturally occurring hormone in the body that plays a crucial role in regulating calcium levels in the blood and promoting bone health[2].

Conditions Treated with Calcitriol

Calcitriol is used to treat various medical conditions, including:

  • Chronic Kidney Disease (CKD): It helps reduce mild proteinuria (excess protein in urine) in patients with CKD[3].
  • X-linked Hypophosphatemia (XLH): A rare genetic disorder affecting phosphate levels and bone mineralization[4].
  • Immune Thrombocytopenia (ITP): A blood disorder causing low platelet counts[5].
  • Vitamin D Deficiency: Particularly in patients with COVID-19[6].
  • Postmenopausal Osteoporosis: To help prevent bone loss[7].

How Calcitriol Works

Calcitriol works in several ways to maintain health:

  • It helps the body absorb calcium from the intestines, which is essential for strong bones and teeth.
  • It regulates phosphate levels in the blood, another mineral crucial for bone health.
  • In patients with kidney disease, it helps compensate for the kidney’s reduced ability to activate vitamin D[3].
  • It may have anti-inflammatory and immune-modulating effects, which could explain its potential benefits in conditions like ITP[5].

How Calcitriol is Administered

Calcitriol can be administered in various ways, depending on the condition being treated:

  • Oral tablets or capsules: These are the most common form, taken daily or as prescribed by a doctor[7].
  • Intravenous (IV) infusion: In some cases, such as in advanced non-small cell lung cancer treatment, calcitriol may be given through an IV[2].
  • Topical application: For certain skin conditions, calcitriol may be applied directly to the skin in ointment form[8].

Ongoing Research and Potential Uses

Researchers are exploring calcitriol’s potential in treating various conditions:

  • Cancer treatment: Studies are investigating its effects on breast cancer[1] and lung cancer[2].
  • COVID-19: Research is ongoing to determine if calcitriol supplementation can benefit COVID-19 patients with vitamin D deficiency[6].
  • Myelodysplastic Syndrome (MDS): A blood disorder where calcitriol may help improve blood cell production[9].
  • Skin conditions: Topical calcitriol is being studied for treating facial angiofibroma in tuberous sclerosis complex[8].

Potential Side Effects and Precautions

While calcitriol can be beneficial, it’s important to be aware of potential side effects:

  • Hypercalcemia: Elevated calcium levels in the blood, which can cause symptoms like nausea, confusion, and kidney problems[2].
  • Kidney calcifications: In some cases, long-term use may lead to calcium deposits in the kidneys[4].
  • Interactions with other medications: Calcitriol can interact with certain drugs, so it’s crucial to inform your doctor about all medications you’re taking[10].

Always follow your doctor’s instructions carefully when taking calcitriol, and report any unusual symptoms promptly.

Aspect Details
Medical Conditions Studied Breast cancer, lung cancer, COVID-19, chronic kidney disease, immune thrombocytopenia, X-linked hypophosphatemia, myelodysplastic syndrome, facial angiofibroma
Administration Methods Oral capsules, intravenous infusions, topical application
Dosage Range Varies by study: 0.25 mcg to 1.0 mcg daily, or higher doses in some trials
Treatment Duration Ranges from a few weeks to several months, depending on the study
Primary Outcomes Measured Changes in disease-specific markers, reduction in symptoms, improvements in quality of life
Potential Side Effects Hypercalcemia (elevated blood calcium levels), monitored closely in trials
Combination Therapies Some studies combine calcitriol with other drugs like chemotherapy agents or phosphate binders
Patient Populations Adults and children, depending on the specific trial and condition being studied

FAQ

  • What is calcitriol? Calcitriol is the biologically active form of vitamin D, also known as 1,25-dihydroxyvitamin D3. It is a hormone that plays a crucial role in regulating calcium levels in the body and is being studied for its potential therapeutic effects in various medical conditions.
  • What medical conditions are being studied with calcitriol in clinical trials? Clinical trials are investigating calcitriol's potential in treating a wide range of conditions, including breast cancer, lung cancer, COVID-19, chronic kidney disease, immune thrombocytopenia, X-linked hypophosphatemia, myelodysplastic syndrome, and facial angiofibroma associated with tuberous sclerosis.
  • How is calcitriol administered in these clinical trials? Calcitriol is administered in various ways depending on the study. Some trials use oral capsules, while others use intravenous infusions. There are also studies exploring topical application of calcitriol for skin conditions.
  • Are there any potential side effects of calcitriol treatment? While calcitriol is generally well-tolerated, some potential side effects may include elevated calcium levels in the blood (hypercalcemia), which is closely monitored in clinical trials. Other side effects may vary depending on the dosage and condition being treated.
  • How long do these clinical trials typically last? The duration of clinical trials varies depending on the study design and objectives. Some trials last for a few weeks or months, while others may continue for several years to assess long-term effects and safety.

Ongoing Clinical Trials on Calcitriol

  • Study on the Effectiveness and Safety of Eneboparatide in Patients with Chronic Hypoparathyroidism

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on the Effectiveness and Safety of Eneboparatide, Calcitriol, and Calcium Carbonate for Patients with Chronic Hypoparathyroidism

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Denmark France Germany Hungary Italy +4

  • Study of encaleret compared to standard care in patients with autosomal dominant hypocalcemia type 1

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Belgium Czechia Denmark France Italy The Netherlands

Glossary

  • Calcitriol: The biologically active form of vitamin D, also known as 1,25-dihydroxyvitamin D3. It is a hormone that regulates calcium levels in the body and is being studied for its potential therapeutic effects.
  • Clinical trial: A research study that tests how well new medical approaches work in people. These studies test new methods of screening, prevention, diagnosis, or treatment of a disease.
  • Proteinuria: The presence of excess proteins in the urine, which can be a sign of kidney disease.
  • Hypercalcemia: A condition characterized by higher than normal levels of calcium in the blood.
  • Myelodysplastic syndrome (MDS): A group of disorders caused by poorly formed or dysfunctional blood cells.
  • X-linked hypophosphatemia (XLH): A rare, genetic disorder characterized by low levels of phosphate in the blood, which can lead to softening and weakening of the bones.
  • Immune thrombocytopenia (ITP): A blood disorder characterized by a decreased number of platelets in the blood, which can lead to easy or excessive bruising and bleeding.
  • Angiofibroma: A benign tumor made up of blood vessels and fibrous tissue, often associated with tuberous sclerosis complex.
  • Tuberous sclerosis complex (TSC): A rare genetic disorder that causes non-cancerous tumors to grow in various parts of the body.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.

References

  1. https://clinicaltrials.gov/study/NCT00926315
  2. https://clinicaltrials.gov/study/NCT00794547
  3. https://clinicaltrials.gov/study/NCT01820832
  4. https://clinicaltrials.gov/study/NCT03748966
  5. https://clinicaltrials.gov/study/NCT04094805
  6. https://clinicaltrials.gov/study/NCT05415254
  7. https://clinicaltrials.gov/study/NCT01293682
  8. https://clinicaltrials.gov/study/NCT03140449
  9. https://clinicaltrials.gov/study/NCT00057031
  10. https://clinicaltrials.gov/study/NCT00925704